Keywords: pharmaceutical, sales, driving, growth, aventis, 2nd-qtr, profits
US pharmaceutical sales driving growth at Aventis as 2nd-qtr profits rise
Article | 02 August 2001
Franco-German group Aventis has reported second-quarter 2001 net incomeof 413 million euros ($361.2 million, an increase of 10.5% over the like, year-earlier period, but ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
